Nettoinventarwert (NAV)
| 4.04 USD | 0.01 USD | 0.36 % |
|---|
| Vortag | 4.03 USD | Datum | 04.11.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Raydium ETP | CH1480821391 | 167.64% | |
| 21Shares Stacks ETP | CH1258969042 | 148.06% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 118.23% | |
| 21Shares Arbitrum ETP | CH1304867463 | 89.09% | |
| 21shares Ethena ETP | CH1506167035 | 78.98% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 189.30% | |
| 21Shares Injective Staking ETP | CH1360612134 | 108.69% | |
| 21Shares Raydium ETP | CH1480821391 | 105.42% | |
| 21Shares Uniswap ETP | CH1135202096 | 98.39% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 78.16% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 99.21% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 83.29% | |
| 21Shares Uniswap ETP | CH1135202096 | 22.57% | |
| 21Shares Raydium ETP | CH1480821391 | 18.65% | |
| 21Shares Injective Staking ETP | CH1360612134 | 16.47% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 1’134’745.96 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 06.11.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.